Determining the Comparative Value of Pharmaceutical Risk-Sharing Policies in Non–Small Cell Lung Cancer Using Real-World Data
Author:
Publisher
Elsevier BV
Subject
Public Health, Environmental and Occupational Health,Health Policy
Reference29 articles.
1. Uncertainty in assessing value of oncology treatments;Mullins;Oncologist,2010
2. Coverage with evidence development, only in research, risk sharing, or patient access scheme? A framework for coverage decisions;Walker;Value Health,2012
3. Performance-based risk-sharing arrangements—good practices for design, implementation, and evaluation: report of the ISPOR Good Practices for Performance-Based Risk-Sharing Arrangements Task Force;Garrison;Value Health,2013
4. Linking payment to health outcomes: a taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturers;Carlson;Health Policy,2010
5. Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers;Adamski;BMC Health Serv Res,2010
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Illustrating the Financial Consequences of Outcome-Based Payment Models From a Payers Perspective: The Case of Autologous Gene Therapy Atidarsagene Autotemcel (Libmeldy®);Value in Health;2024-08
2. Lessons learned from the Canadian Fabry Disease Initiative for future risk-sharing and managed access agreements for pharmaceutical and advanced therapies in Canada;Health Policy;2024-05
3. Goals and methods of managed entry agreements – can we get what we want?;Health Policy and Technology;2023-06
4. Value-Based Pricing for Specialty Drugs: Solving the implementation puzzle using Blockchain;2022 OPJU International Technology Conference on Emerging Technologies for Sustainable Development (OTCON);2023-02-08
5. Social pharmaceutical innovation and alternative forms of research, development and deployment for drugs for rare diseases;Orphanet Journal of Rare Diseases;2022-09-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3